CS
VIVE

Credit Suisse’s VIVEVE MED INC VIVE Stock Holding History

Credit Suisse’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11
Closed -$59K – 4261
2017
Q3 		$59K Buy
+11
New +$67.8K ﹤0.01% 4137

Other funds holding VIVE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Credit Suisse's VIVE Position: Q4 2017 in Review

Credit Suisse sold out of VIVEVE MED INC (VIVE) in Q4 2017, closing a stake of 11 shares — an estimated $59K sold.

Credit Suisse first reported a position in VIVE in Q3 2017 and held it in 1 quarter. The position peaked at $59K in Q3 2017. 44 funds tracked by Wall St. Rank hold VIVE as of Q4 2017.

  • Credit Suisse reported no remaining VIVEVE MED INC position as of Q4 2017 after selling out during the quarter.
  • Credit Suisse sold 11 VIVEVE MED INC shares in Q4 2017, an estimated $59K.
  • Credit Suisse first reported a position in VIVEVE MED INC in Q3 2017 and held it in 1 quarter.
  • Credit Suisse's VIVEVE MED INC position peaked at $59K in Q3 2017.
  • 44 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q4 2017.

Based on Credit Suisse's 13F filing for Q4 2017, filed 14 Feb 2018.